EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Direct questions

19. What evidence should be in a GLP-1 supplier due-diligence file?

Dose Diligence research deskSection 01 · Page 19 of 34Last updated 17 Nov 2026

Build the file around the specific facility and proposed arrangement. Separate identity, regulatory status, inspection history, product provenance and operational capability.

Recommended evidence register:

AreaEvidence to obtain or independently check
IdentityContracting entity, producing facility, dispensing pharmacy and shipping subcontractors
PermissionsRelevant licences, registrations and scope
Inspection historyFDA and state findings, responses, corrective actions and subsequent status
Product sourcingAuthorized distribution evidence or applicable ingredient documentation
QualityRelease controls, complaint handling and relevant testing information
HandlingStorage, shipping validation and excursion disposition
Recall readinessProduct/lot identification and affected-patient notification process
Commercial resilienceInsurance, financial information, deposits and transition obligations

FDA’s outsourcing register provides registration and selected inspection/action information. FDA also maintains a separate compounding inspections, recalls and actions resource. (fda.gov)

A Form FDA 483 records inspection observations; it is not itself a final agency determination of a violation. Review the subsequent response and disposition rather than treating the form as either an automatic ban or an irrelevant historical document. (fda.gov)

FDA explicitly states that outsourcing registration does not establish CGMP compliance or satisfaction of every 503B condition. (fda.gov)

Explore the table row by row

A working view of the research

Identity

Evidence to obtain or independently check
Contracting entity, producing facility, dispensing pharmacy and shipping subcontractors

Sources cited on this page

  1. fda.gov · Source 1 ↗https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities?utm_source=openai
  2. fda.gov · Source 2 ↗https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/inspection-references/fda-form-483-frequently-asked-questions?trk=article-ssr-frontend-pulse_little-text-block&utm_source=openai
  3. fda.gov · Source 3 ↗https://www.fda.gov/drugs/human-drug-compounding/questions-and-answers-outsourcing-facility-registration?utm_source=openai
Section sources →